Home  |  Archive  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

Links

Meetings
Journals
Societies & Institutes
Hospitals
Databases & Libraries
Companies
Websites
Other links

 
Prostate Disease

Volume 20, Issue 3 (May 2018)
The path forward in prostate cancer therapeutics
Jeanny B Aragon-Ching1, Ravi A Madan2
Asian J Androl 20: 213-214; DOI: 10.4103/aja.aja_3_18
Full TextPDF PDF

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
Tanya B Dorff1, Neeraj Agarwal2
Asian J Androl 20: 215-220; 10.4103/aja.aja_12_18
Abstract |Full TextPDF PDF

Role of chemotherapy in prostate cancer
Rita Nader1, Joelle El Amm2, Jeanny B Aragon-Ching3
Asian J Androl 20: 221-229; 10.4103/aja.aja_40_17
Abstract |Full TextPDF PDF

Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer
Theodore Gourdin1, Guru Sonpavde2
Asian J Androl 20: 230-237; 10.4103/aja.aja_1_18
Abstract |Full TextPDF PDF

The role of peroxisome proliferator-activated receptor gamma in prostate cancer
Catherine Elix, Sumanta K Pal, Jeremy O Jones
Asian J Androl 20: 238-243; 10.4103/aja.aja_15_17
Abstract |Full TextPDF PDF

Vitamin D in prostate cancer
Donald L Trump, Jeanny B Aragon-Ching
Asian J Androl 20: 244-252; 10.4103/aja.aja_14_18
Abstract |Full TextPDF PDF

Perspectives on the clinical development of immunotherapy in prostate cancer
Lisa M Cordes1,2, James L Gulley2, Ravi A Madan2
Asian J Androl 20: 253-259; 10.4103/aja.aja_9_18
Abstract |Full TextPDF PDF

Intermittent, low-dose, antiandrogen monotherapy as an alternative therapeutic option for patients with positive surgical margins after radical prostatectomy
Kyung Hwa Choi, Seung Ryeol Lee, Young Kwon Hong, Dong Soo Park
Asian J Androl 20: 270-275; 10.4103/aja.aja_56_17
Abstract |Full TextPDF

The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines
Octavio Orellana-Serradell, Daniela Herrera, Enrique A Castellon, Hector R Contreras
Asian J Androl 20: 294-299; 10.4103/aja.aja_61_17
Abstract |Full TextPDF

ASIC1a contributes to the symptom of pain in a rat model of chronic prostatitis
Song Fan1,2, Zong-Yao Hao1,2, Li Zhang1.2, Jun Zhou1,2, Yi-Fei Zhang1,2, Shen Tai1,2, Xian-Sheng Zhang1,2, Chao-Zhao Liang1,2
Asian J Androl 20: 300-305; 10.4103/aja.aja_55_17
Abstract |Full TextPDF

[首页] [前一页][后一页] [尾页]  共有47页,10条记录

 
Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved